Načítá se...

‘Tamsulosin and Darifenacin’ Versus ‘Tamsulosin Monotherapy’ for ‘BPH with Accompanying Overactive Bladder’

PURPOSE: To evaluate the efficacy/safety of ‘tamsulosin and darifenacin’ (TD) vs. ‘tamsulosin and placebo’ (TP) for patients with symptomatic benign prostrate hyperplasia (BPH) with accompanying overactive bladder (OAB) symptoms. MATERIALS AND METHODS: This study included symptomatic patients of BPH...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Clin Diagn Res
Hlavní autoři: Singh, Iqbal, Agarwal, Vivek, Garg, Gaurav
Médium: Artigo
Jazyk:Inglês
Vydáno: JCDR Research and Publications (P) Limited 2015
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4525548/
https://ncbi.nlm.nih.gov/pubmed/26266159
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7860/JCDR/2015/12526.6019
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!